Information about GlobalPharmacyMeds.to
List of countries where we can ship Pirfenidone:
Latest news releases on Pirfenidone:
Learn about Esbriet® (pirfenidone), a medicine for treating idiopathic pulmonary fibrosis, a progressive and irreversible fibrotic interstitial lung disease.
Background In two of three phase 3 trials, pirfenidone, an oral antifibrotic therapy, reduced disease progression, as measured by the decline in forced vital capacity ...
Medicinas Online Canada es la farmacia online para Pirfenidone tienda de calidad y precios bajos para Pirfenidone, con informacion completa de Pirfenidone
Drugs Affecting TGF-β Activity: Pirfenidone. Pirfenidone is an orally active pyridone derivative that has been approved in Europe as an anti-fibrotic drug for the ...
The new england journal of medicine n engl j med 370;22 nejm.org29, 2014 may 2083 original article A Phase 3 Trial of Pirfenidone in Patients with Idiopathic ...
Pirfenidone is a small, synthetic molecule under investigation for treatment of idiopathic pulmonary fibrosis. In an open-label, single-dose crossover study, the ...
Find patient medical information for Pirfenidone Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
[Pirfenidone] [53179-13-8] | 価格や在庫、物性値などの詳細情報ページです。
Approximately 70–80% of pirfenidone is metabolised via CYP1A2 with minor contributions from other CYP isoenzymes including CYP2C9, 2C19, 2D6, and 2E1.
Esbriet 267 mg film-coated tablets. Esbriet 534 mg film-coated tablets. Esbriet 801 mg film-coated tablets